China’s Medical Devices and Health Technology Industry: Strict Standards and Golden Opportunities
China’s National Medical Products Administration (NMPA) issued a new strategy on July 3, 2025, to advance high-quality medical devices, including 10 regulatory measures aimed at accelerating the development of innovative medical technologies. Key Objectives of the Strategy Supporting the development of advanced medical devices domestically and globallyThe policy prioritizes technologies with high clinical value and international leadership potential, including: Regulatory Improvements at Every Stage Innovation and ClassificationSpecific classification guidelines have been developed for medical robots, with the formation of joint expert consensus on naming conventions. Standards SystemAccelerating standards development for technologies such as: Approval and Registration Process Communication and Consultation Mechanisms Implications for Foreign and Domestic Companies For Foreign Companies: Increasing Compliance Expectations: